Molecule Details
| InChIKey | NCGUZWKSZMMNCP-TWLAMCEISA-M |
|---|---|
| Compound Name | (5R),(6Z)-7-oxo-6-(4,5,6,7-tetrahydropyrazolo[1,5-a]-pyrazin-2-ylmethylene)-4-thia-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium salt |
| Canonical SMILES | O=C([O-])C1=CS[C@@H]2/C(=C\c3cc4n(n3)CCNC4)C(=O)N12 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Unknown |
| Avg pChEMBL | 7.8 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P62593 | bla | Escherichia coli | Pathogen | PF13354 | 9.0 | IC50 | ChEMBL;BindingDB |
| P05364 | ampC | Enterobacter cloacae | Pathogen | PF00144 | 8.5 | IC50 | ChEMBL;BindingDB |
| P52663 | nmcA | Enterobacter cloacae | Pathogen | PF13354 | 6.9 | IC50 | ChEMBL;BindingDB |
| P25910 | ccrA | Bacteroides fragilis | Pathogen | — | 6.8 | IC50 | ChEMBL;BindingDB |